Viiv Health Care Stock Ticker

Listing Websites about Viiv Health Care Stock Ticker

Filter Type:

ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance S…

(6 days ago) People also askWho owns ViiV Healthcare?(RTTNews) - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer Inc. (PFE) and Shionogi Limited as shareholders, said that the US Food and Drug Administration approved Apretude, long-acting injectable pre-exposure prophylaxis option to reduce the risk of sexually acquired HIV-1.ViiV Healthcare : FDA Approves Apretude, Long-acting Injectable Optio…markets.businessinsider.comWhat is ViiV Healthcare's market share?ViiV Healthcare's products have a market share of approximately 32% of the global HIV therapy market, making it the second-largest healthcare company in the sector, after Gilead Sciences.ViiV Healthcare - Wikipediaen.wikipedia.orgDoes ViiV Healthcare have a co-ownership structure?According to The Financial Times, the company’s co-ownership structure may change depending on the achievement of certain milestones. ViiV Healthcare's products have a market share of approximately 32% of the global HIV therapy market, making it the second-largest healthcare company in the sector, after Gilead Sciences.ViiV Healthcare - Wikipediaen.wikipedia.orgDoes ViiV Healthcare have a not-for-profit pricing program?ViiV Healthcare has stated that it will continue the not-for-profit pricing schemes that Pfizer and GlaxoSmithKline had been involved in prior to the setting up of the company. This program covers all low- and middle-income countries, as well as all of Sub-Saharan Africa.ViiV Healthcare - Wikipediaen.wikipedia.orgFeedbackBloomberghttps://www.bloomberg.com/profile/company/3452591Z:LNViiV Healthcare Ltd - Company Profile and News - Bloomberg …WebCompany profile page for ViiV Healthcare Ltd including stock price, company news, executives, board members, and contact information

https://seekingalpha.com/article/3452586-viiv-healthcare-hidden-gem-of-glaxosmithklines-balance-sheet#:~:text=ViiV%20Healthcare%20is%20a%20consolidated%20division%20of%20GlaxoSmithKline,treatment%20and%20care%20for%20people%20living%20with%20HIV.

Category:  Food Show Health

GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With …

(Just Now) WebViiV Healthcare, majority-owned by GSK Plc (NYSE: GSK), Pfizer Inc (NYSE: PFE), and Shionogi Limited, announced 12-month findings from the SOLAR …

https://finance.yahoo.com/news/gsk-pfizer-backed-viiv-healthcares-154336744.html

Category:  Health Show Health

ViiV Healthcare announces U.S. FDA approval of Dovato …

(7 days ago) WebDURHAM, N.C., April 08, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the U.S. …

https://finance.yahoo.com/news/viiv-healthcare-announces-u-fda-122300021.html

Category:  Health Show Health

ViiV Healthcare : FDA Approves Apretude, Long-acting - Nasdaq

(2 days ago) Web(RTTNews) - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer Inc. (PFE) and Shionogi …

https://www.nasdaq.com/articles/viiv-healthcare-%3A-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention

Category:  Health Show Health

ViiV Healthcare - Markets Insider

(5 days ago) Web(RTTNews) - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer Inc. (PFE) and Shionogi …

https://markets.businessinsider.com/news/stocks/viiv-healthcare-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention-1031058136

Category:  Health Show Health

ViiV Healthcare's Cabenuva Shows Superiority In HIV Viral Load

(6 days ago) Web(RTTNews) - ViiV Healthcare announced results from an interim analysis of the LATITUDE phase III trial, indicating their long-acting injectable antiretroviral …

https://markets.businessinsider.com/news/stocks/viiv-healthcare-s-cabenuva-shows-superiority-in-hiv-viral-load-suppression-interim-trial-analysis-1033086273

Category:  Health Show Health

ViiV Healthcare : FDA Approves Label Update For Long-acting HIV

(9 days ago) WebMar. 24, 2022, 10:29 PM. (RTTNews) - The US Food and Drug Administration approved a label update for long-acting HIV treatment Cabenuva (cabotegravir, rilpivirine), allowing …

https://markets.businessinsider.com/news/stocks/viiv-healthcare-fda-approves-label-update-for-long-acting-hiv-treatment-cabenuva-1031306584

Category:  Food Show Health

GlaxoSmithKline's ViiV Healthcare Receives FDA Approval For

(4 days ago) Web(RTTNews) - ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer and Shionogi Limitedas …

https://www.nasdaq.com/articles/glaxosmithklines-viiv-healthcare-receives-fda-approval-for-hiv-treatment

Category:  Health Show Health

ViiV Healthcare announces FDA approval of two-month dosing of …

(6 days ago) Webjarun011/iStock via Getty Images. ViiV Healthcare, majority-owned by GlaxoSmithKline (NYSE:GSK), announced that the FDA approved an every-two-month …

https://seekingalpha.com/news/3794065-viiv-healthcare-announces-fda-approval-of-two-month-dosing-of-cabenuva-for-hiv

Category:  Health Show Health

ViiV Healthcare announces interim data at CROI indicating …

(8 days ago) WebViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced data from a …

https://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/ViiV-Healthcare-announces-interim-data-at-CROI-indicating-superior-efficacy-of-long-acting-injectabl-46111440/

Category:  Health Show Health

ViiV Healthcare to present data for its next generation of ultra long

(9 days ago) WebLondon - GSK plc (LSE/NYSE: GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as …

https://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/ViiV-Healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-treatments-for-HIV-46064084/

Category:  Health Show Health

The Hidden Gem Of GlaxoSmithKline's Balance Sheet - Seeking …

(1 days ago) WebViiV healthcare is invisible on GSK's balance sheet with a negative net position of contingent consideration outweighing intangible assets by £0.7 BN ($1.1 BN). …

https://seekingalpha.com/article/3452586-viiv-healthcare-hidden-gem-of-glaxosmithklines-balance-sheet

Category:  Health Show Health

ViiV Healthcare - Wikipedia

(5 days ago) WebViiV Healthcare (/ ˈ v iː v / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent …

https://en.wikipedia.org/wiki/ViiV_Healthcare

Category:  Medicine Show Health

GSK’s global HIV business ViiV Healthcare completes transactions …

(Just Now) WebIssued: London. GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi …

https://www.gsk.com/en-gb/media/press-releases/gsk-s-global-hiv-business-viiv-healthcare-completes-transactions-to-acquire-bristol-myers-squibb-s-rd-hiv-assets/

Category:  Health Show Health

ViiV Healthcare announces new packaging option now available in …

(8 days ago) WebViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in …

https://finance.yahoo.com/news/viiv-healthcare-announces-packaging-option-160000818.html

Category:  Health Show Health

ViiV Healthcare Ltd Reuters

(2 days ago) WebFebruary 22, 2023. 1 to 3 of 3. The latest international ViiV Healthcare Ltd news and views from Reuters - one of the world's largest news agencies.

https://www.reuters.com/company/viiv-healthcare-ltd/

Category:  Health Show Health

GlaxoSmithKline : ViiV Healthcare shares data from its innovative

(2 days ago) WebAbout ViiV Healthcare. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) …

https://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/GlaxoSmithKline-ViiV-Healthcare-shares-data-from-its-innovative-portfolio-with-HIV-community-at-IA-24789095/

Category:  Health Show Health

GSK: ViiV Healthcare Gets FDA Approval For HIV Treatment …

(5 days ago) Web(RTTNews) - GlaxoSmithKline plc (GSK, GSK.L) said Friday that its majority-owned specialist HIV company ViiV Healthcare has received approval from the US Food …

https://markets.businessinsider.com/news/stocks/gsk-viiv-healthcare-gets-fda-approval-for-hiv-treatment-cabenuva-quick-facts-1029993099

Category:  Food Show Health

GlaxoSmithKline: 4.57% Dividend Yield, Cure For COVID-19 & HIV

(2 days ago) WebSales of Sotrovimab for COVID-19 were £114 million in Q3 2021, up 612.5% from Q2 2021. ViiV Healthcare, majority-owned by GlaxoSmithKline, wins litigation …

https://seekingalpha.com/article/4483866-glaxosmithkline-4-57-percent-dividend-yield-cure-covid-19-hiv

Category:  Health Show Health

Viiv Healthcare : The latest share price - Sharecast.com

(8 days ago) Web*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity;

https://www.sharecast.com/equity/Viiv_Healthcare

Category:  Health Show Health

Filter Type: